Considering the regulatory role of STAT3 in breast cancer drug resistance and tumorigenesis, the exploration of new STAT3 inhibitors will assist the development new STAT3-targeted anti-cancer therapies for breast cancer. The gene discussed is STAT3; the disease is breast cancer.